Close
Top Videos
Top Searches
Moods
Black Lives Matter
Chill
Christmas
Commute
Energy boosters
Feel-Good
Focus
Party
Pride
Romance
Sad
Sleep
Workout
Genres
African
Arabic
Blues
Bollywood & Indian
Christian & Gospel
Classical
Country and Americana
Dance and electronic
Decades
Family
Folk and acoustic
Hip-hop
Indie and alternative
J-Pop
Jazz
K-Pop
Latin
Mandopop & Cantopop
Metal
Pop
R&B and Soul
Reggae and Caribbean
Rock
Soundtracks and musicals
Sustaining the momentum toward universal health coverage in Africa
04:10
|
Download MP3
Related Videos
1:16
Novartis mission
6:51
Novartis CEO discusses how AI will impact drug development
4:43
Novartis CEO: Our leukemia drug Scemblix is a potential $3 billion plus medicine
0:54
Novartis as a focused innovative medicines company
2:59
25 Years of Novartis – Continuing our innovation journey
0:52
Novartis – Who We Are
0:34
Novartis, Sandoz recall 12 medications over packaging concerns
3:01
Novartis Research & Development
1:58
Novartis Raises Outlook After Sandoz Generics Spinoff
1:13
Novartis Cancer Drug Is Approved With $475,000 Price Tag
1:12
Research and Development: It’s our heartbeat.
2:14
Manufacturing CAR-T Cell Therapies: The Novartis Approach
0:59
Novartis Oncology - BOLD Science. Transforming Lives. Striving For Cures.
24:07
Novartis CEO Vas Narasimhan on The David Rubenstein Show
4:19
Novartis CEO on Acquisitions, AI, Weight-Loss Drugs
1:40
Long Live Life: Connecting with the Novartis Mission
1:12
Welcome to where we thrive together
3:43
Novartis CEO Vas Narasimhan on the latest research on a breast cancer drug
1:37
Corporate responsibility at Novartis
5:48
Novartis Financial Results Q3 2019
1:16 6:51 4:43 0:54 2:59 0:52 0:34 3:01 1:58 1:13 1:12 2:14 0:59 24:07 4:19 1:40 1:12 3:43 1:37 5:48
1:16
